Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...
Scientists have created a new type of drug, called KTX207, that works by specifically instructing cells to destroy certain proteins, rather than just blocking them. This new drug targets...
Researchers have developed a new approach to T cell therapy that is more effective and less toxic than current treatments. This new approach uses bispecific T cell engagers (BITEs)...
Researchers from Chulalongkorn University have developed a new weapon against glioblastoma, a notoriously difficult-to-treat brain cancer, in the form of a brand-new antibody. This antibody is a key component...
CD99 is highly expressed in T cell acute lymphoblastic leukemia (T-ALL), a type of cancer. One promising treatment involves a mouse monoclonal antibody against CD99 called mAb MT99/3, which...
A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The...
Researchers have developed a new approach to T cell therapy that is more effective in killing breast cancer cells. This new approach uses bispecific T cell engagers (BITEs) to...
A follow-up study on 50 adults investigated the impact of PM2.5 exposure on ocular health. Samples were collected before and after the high PM2.5 season, utilizing data from the...
A new study has explored the potential of generating T lymphocytes from hematopoietic stem cells (HSCs) for cancer immunotherapy. HSCs are a type of cell that can differentiate into...
Researchers from Siriraj Hospital, Mahidol University in Thailand have successfully used a closed, semi-automated production platform to produce anti-CD19 CAR-T cells for the treatment of relapsed/refractory B-cell malignancies. This...